Carcinoma in situ of nasolacrimal duct   416921001

SNOMED CT code


SNOMED code416921001
nameCarcinoma in situ of nasolacrimal duct
statusactive
date introduced2005-07-31
fully specified name(s)Carcinoma in situ of nasolacrimal duct (disorder)
synonymsCarcinoma in situ of nasolacrimal duct
attributes - group1
Associated morphologyCarcinoma in situ   1187138006
Finding siteNasolacrimal duct structure   15753006
parents
  • Neoplasm of nasolacrimal duct   416753001
  • Carcinoma in situ of lacrimal gland duct   422893006
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Clinical finding   404684003
    Eye / vision finding   118235002
      Lacrimal system finding   416270005
        Lacrimal drainage pathway finding   246854005
          Disorder of lacrimal passage   27091000119107
            Neoplasm of lacrimal drainage system   419889000
              Neoplasm of nasolacrimal duct   416753001
                Carcinoma in situ of nasolacrimal duct   416921001

SNOMED CT Concept   138875005
  Clinical finding   404684003
    Eye / vision finding   118235002
      Lacrimal system finding   416270005
        Lacrimal drainage pathway finding   246854005
          Disorder of lacrimal passage   27091000119107
            Neoplasm of lacrimal drainage system   419889000
              Carcinoma in situ of lacrimal drainage system   422607004
                Carcinoma in situ of lacrimal gland duct   422893006
                  Carcinoma in situ of nasolacrimal duct   416921001

ancestors
sorted most to least specific
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.